Please provide your email address to receive an email when new articles are posted on . Since May 2023, a combination of neuraminidase mutations has been detected in influenza A(H1N1)pdm09 viruses.

Lenacapavir (LEN) is an antiviral medication used to treat and prevent HIV/AIDS and was first approved for individuals with drug-resistant infections in 2022. While there is still no vaccine for the ...

Tamiflu, the same antiviral used to treat ordinary seasonal influenza, is the front line medication recommended for treating highly pathogenic bird flu (Photo by Rui Vieira/PA Images via Getty Images) ...

New research has identified a genetic mutation that confers resistance to cassava mosaic disease (CMD). Groundbreaking research led by Rebecca Bart, PhD, associate member, and Nigel Taylor, PhD, ...

The virus that causes COVID-19 might be becoming resistant to antiviral treatments, new research has warned. But should we be concerned? The antiviral drugs nirmatrelvir and remdesivir are recommended ...

Gloved fingers hold a labeled vial of lenacapavir, a clear, yellowish liquid. Lenacapavir (shown) is an antiretroviral medication used to help prevent and treat HIV. Credit: Associated Press While ...

Laura holds a Master's in Experimental Neuroscience and a Bachelor's in Biology from Imperial College London. Her areas of expertise include health, medicine, psychology, and neuroscience. Laura holds ...

A new study headed by teams at the Wellcome Sanger Institute, EMBL’s European Bioinformatics Institute (EMBL-EBI), and Open Targets has indicated how mutations that cause cancer drug resistance fall ...

The patient in Louisiana who was hospitalized with severe bird flu illness was found to have a mutated version of the virus, the U.S. Centers for Disease Control and Prevention (CDC) announced last ...